Patent Assignment
Reel/Frame 047408/0754
Assignment of Assignor's Interest
Recorded: 2018-11-05
Pages: 10
Assignors
ONIK, GARY M.
Executed: 2018-07-02
MIESSAU, JAMES A.
Executed: 2018-06-02
BOSTWICK, DAVID G.
Executed: 2018-07-06
Assignee
RFEMB HOLDINGS, LLC
4724 LAKE CALABY DRIVE, ORLANDO, FLORIDA, 32837
Covered Properties
(22)
Radio-Frequency Electrical Membrane Breakdown for the Treatment of High Risk and Recurrent Prostate Cancer, Unresectable Pancreatic Cancer, Tumors of the Breast, Melanoma or Other Skin Malignancies, Sarcoma, Soft Tissue Tumors, Ductal Carcinoma, Neoplasia, and Intra and Extra Luminal Abnormal Tissue
Catheter Based Radio-Frequency Electrical Membrane Breakdown for the Treatment of Ductal Carcinoma, Neoplasia and Intra and Extra Luminal Abnormal Tissue from an Intraluminal Location
Application:
62/111,870 →
Radio-Frequency Electrical Membrane Breakdown for the Treatment of Unresectable Pancreatic Cancer and Adjuvant Immunotherapy
Application:
62/110,646 →
Apparatus and Method for Radio-Frequency Electrical Membrane Breakdown Treatment of Tumors of the Breast with Immunologic Enhancement Through Enhanced Antigen Presentation
Application:
62/110,674 →
Apparatus and Method for Radio-Frequency Electrical Membrane Breakdown Treatment of Melanoma or Other Skin Malignancy with Immunologic Enhancement Through Enhanced Antigen Presentation
Application:
62/110,702 →
Radio-Frequency Electrical Membrane Breakdown for the Treatment of Sarcoma and Soft Tissue Tumors Using Adjuvant Immunotherapy
Application:
62/110,733 →
Radio-Frequency Electrical Membrane Breakdown for the Treatment of High Risk and Recurrent Prostate Cancer Using a Minimally Invasive Office Based Procedure and Adjuvant Immunotherapy
Application:
62/109,965 →
Radio-Frequency Electrical Membrane Breakdown for the Treatment of Cardiac Rhythm Disorders and for Renal Neuromodulation
Application:
15/549,194 →
Publication:
US 2018/0028264
Radio-Frequency Electrical Membrane Breakdown for the Treatment of Cardiac Rhythm Disorders
Application:
62/112,742 →
Radio-Frequency Electrical Membrane Breakdown for Renal Neuromodulation
Application:
62/112,844 →
Radio-Frequency Electrical Membrane Breakdown for Reducing Restenosis
Application:
15/548,935 →
Publication:
US 2018/0021084
Radio-Frequency Electrical Membrane Breakdown for Reducing Restenosis
Application:
62/112,059 →
Radio-Frequency Electrical Membrane Breakdown for the Treatment of Benign Prostatic Hyperplasia
Application:
15/548,877 →
Publication:
US 2018/0028267
Radio-Frequency Electrical Membrane Breakdown for the Treatment of Benign Prostatic Hyperplasia
Application:
62/111,854 →
Radio-Frequency Electrical Membrane Breakdown for the Treatment of Adipose Tissue and Removal of Unwanted Body Fat
Application:
15/548,908 →
Publication:
US 2018/0028260
Radio-Frequency Electrical Membrane Breakdown for the Treatment of Adipose Tissue and Removal of Unwanted Body Fat
Application:
62/112,047 →
Radio-Frequency Electrical Membrane Breakdown for the Treatment of High Risk and Recurrent Prostate Cancer, Unresectable Pancreatic Cancer, Tumors of the Breast, Melanoma or Other Skin Malignancies, Sarcoma, Soft Tissue Tumors, Ductal Carcinoma, Neoplasia, and Intra and Extra Luminal Abnormal Tissue
PCT:
PCT/US2016/015944 ↗
Radio-Frequency Electrical Membrane Breakdown for the Treatment of Cardiac Rhythm Disorders and for Renal Neuromodulation
PCT:
PCT/US2016/016955 ↗
Radio-Frequency Electrical Membrane Breakdown for Reducing Restenosis
PCT:
PCT/US2016/016501 ↗
Radio-Frequency Electrical Membrane Breakdown for the Treatment of Benign Prostatic Hyperplasia
PCT:
PCT/US2016/016300 ↗
Radio-Frequency Electrical Membrane Breakdown for the Treatment of Adipose Tissue and Removal of Unwanted Body Fat
PCT:
PCT/US2016/016352 ↗
Immunologic Treatment of Cancer
PCT:
PCT/US2017/013486 ↗
Related Assignments
(1)
Other recorded transfers of the patents in this record — the chain of ownership.